Cargando…

A Prospective Randomised Comparative Clinical Trial Study of Luteal Phase Letrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is the most notable complication in ovulation induction for assisted reproductive techniques (ARTs) like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Hence, we decided to evaluate the effect of the aromatase inhibitor,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choudhary, Rana Afzal, Vora, Priyanka H, Darade, Kavita K, Pandey, Seema, Ganla, Kedar N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530210/ https://www.ncbi.nlm.nih.gov/pubmed/34913294 http://dx.doi.org/10.22074/IJFS.2021.139562.1042

Ejemplares similares

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Sildenafil Citrate: Novel Therapy in the Management of Ovarian Torsion
por: Ganla, Kedar N., et al.
Publicado: (2019)

Sildenafil citrate for the management of fetal growth restriction and oligohydramnios
por: Choudhary, Rana, et al.
Publicado: (2016)

Ganirelix and the prevention of premature luteinizing hormone surges
por: Mannaerts, Bernadette
Publicado: (2023)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study
por: Lainas, George T, et al.
Publicado: (2012)

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?
por: Wang, Ya-Qin, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

OHSS Free Clinic
por: Devroey, P., et al.
Publicado: (2011)

Effects of metformin and ganirelix on subcutaneous endometriosis in a mouse model of autophagy-related cell death
por: Sönmez Ünal, Gamze, et al.
Publicado: (2023)

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Ureteric Injury During Transvaginal Oocyte Retrieval (TVOR) and Review of Literature
por: Choudhary, Rana A., et al.
Publicado: (2017)

Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation
por: Frattarelli, John L, et al.
Publicado: (2013)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
por: Yanagihara, Yasuho, et al.
Publicado: (2021)

An unusually prolonged course of late onset severe OHSS with successful outcome - a rare but avoidable complication
por: Malhotra, Neena, et al.
Publicado: (2022)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial
por: Ferrero, Simone, et al.
Publicado: (2011)

Luteal blood flow and luteal function
por: Takasaki, Akihisa, et al.
Publicado: (2009)

Are Pregnancy Rates Compromised Following Embryo Freezing to Prevent OHSS?
por: Fitzmaurice, Gerard J, et al.
Publicado: (2008)

Predictive factors for recovery time in patients suffering from severe OHSS
por: Nouri, Kazem, et al.
Publicado: (2014)

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
por: Banker, Manish, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!
por: Petrenko, Aleksei Petrovich, et al.
Publicado: (2022)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage
por: Haas, Jigal, et al.
Publicado: (2014)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Biomarkers identification in follicular fluid of women with OHSS by using UPLC-MS method
por: Wu, Ze, et al.
Publicado: (2023)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
por: Lalami, Imane, et al.
Publicado: (2022)

Assessment of Fertility Outcomes Following Combined Clomiphene and Letrozole Versus Letrozole Therapy for the Treatment of Polycystic Ovarian Syndrome Subfertility
por: Sharma, Priyanka, et al.
Publicado: (2023)

Regression of Late Onset Choroidal Metastasis from a Breast Carcinoma with Letrozole
por: Cancino, Reinaldo, et al.
Publicado: (2011)

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence
por: Li, Yiran, et al.
Publicado: (2019)

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2008)

Letrozole for Female Infertility
por: Yang, Ai-Min, et al.
Publicado: (2021)

Can luteal regression be reversed?
por: Telleria, Carlos M
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dp7tf127ajjdperrd3ggjf3ke8